Clinical Trial Update: Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update of Reolysin in previously treated advanced/metastatic non-small cell lung cancer patients receiving standard salvage therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• REOLYSIN (pelareorep)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED